Navigation Links
China Nepstar Chain Drugstore Awarded Prestigious Title of '2007 Best Drugstore Chain in China' by China Drugstore Magazine
Date:4/10/2008

r example, In March 2008, it launched a charitable initiative to raise awareness of women's health issues among low-income working women residents in Guangdong Province.

About China Nepstar Chain Drugstore Ltd.

China Nepstar Chain Drugstore Ltd. (NYSE: NPD) is China's largest retail drugstore chain based on the number of directly operated stores. As of December 31, 2007, the Company had 2,002 stores across 62 cities, one headquarters distribution center and 11 regional distribution centers in China. China Nepstar uses directly operated stores, centralized procurement and a network of distribution centers to provide customers with high-quality, professional and convenient Drugstore services and a wide variety of other merchandise, including over-the-counter ("OTC") drugs, nutritional supplements, herbal products, personal care products, family care products, and convenience products including consumables. China Nepstar's strategy of centralized procurement, competitive pricing, customer loyalty programs and private label offerings has enabled it to capitalize on the robust economic growth in China and to take advantage of the demographic trend in China to achieve a strong brand and leading market position. For further information, please go to http://www.nepstar.cn .

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by
'/>"/>

SOURCE China Nepstar Chain Drugstore Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. China Sky One Medical, Inc. Closes Acquisition of Heilongjiang Tianlong Pharmaceutical, Inc.
2. Town Health and Ping An Insurance (Group) Company of China, Ltd. Join Forces to Develop and Manage Clinic Chain in Pearl River Delta Area
3. Mindray to Attend the JPMorgan 4th Annual China Conference
4. Escalon(R) Announces China Registration for Sonomed PacScan(R) and E/Z-Scan(R) Series of A-scan, Pachymeter and B-Scan Systems
5. China Medical Technologies Completed the Development of Prostate Cancer FISH Reagent
6. China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results
7. China Shenghuo Pharmaceutical Holdings, Inc. to Present at Brean Murray Carret & Co. Mainland China Investor Tour
8. China Nepstar Chain Drugstore to Accept TransCard at Shenzhen Outlets
9. China Bionanometer Industries (CBIU) Describes their Current Production Capacity and Product Lines
10. Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.s Fourth Investor Tour of China
11. China Shenghuo Reports Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Portland, OR (PRWEB) March 02, 2015 ... its plan to remake American healthcare. Zoom will ... include 28 neighborhood clinics and advanced care studios ... mental health, emergency services, specialty care and outpatient ... provide on-demand access to almost all healthcare needs ...
(Date:3/2/2015)... Birmingham, Alabama (PRWEB) March 02, 2015 ... Alabama - In conjunction with Women in Construction Week ... in Construction, or NAWIC) and National Women’s History Month, ... and commitment positively affect the company and the construction ... the management team, to the dozens of roles in ...
(Date:3/2/2015)... Burns Engineering's Lab-to-Lab Calibration Service ... Standard Platinum Resistance Thermometers (SSPRTs) and industrial Resistance ... less . . . guaranteed. Their ... Code 200706-0), ISO 9001 and 17025 Certified and ... -196°C to 500°C, both ITS-90 and Callendar-van Dusen ...
(Date:3/2/2015)... The Workgroup for Electronic Data Interchange (WEDI), the ... IT to create efficiencies in healthcare information exchange, released ... The white paper by WEDI’s ICD-10 Testing Subworkgroup provides ... by focusing on primary considerations and steps for external ... 1, 2015 implementation date. Download the white paper ...
(Date:3/2/2015)... March 02, 2015 Representatives with ... has officially launched a multivitamin supplement that’s specifically ... product development for BNatrl, said the multivitamin, which ... Olympic and other world-class athletes. , "Being an ... this pure whole food multivitamin to improve my ...
Breaking Medicine News(10 mins):Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 3Health News:Robins & Morton Recognizes Women In Construction 2Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:Bnatrl Launches Multivitamin Supplement for Runners 2
... Cost Saving Benefit Faces Eventual Elimination Without Relief ... support of President Obama,s pledge not to raise taxes on ... -- outside of the normal legislative process -- adopting provisions ... restrict the use of flexible spending accounts (FSAs) in order ...
... Oct. 14 New Enterprise Associates, Inc. (NEA), a leading ... has been promoted to General Partner. Dr. Viswanathan, who joined ... equity information technology investments, as well as the firm,s activities ... Principal. Dr. Torti joined NEA in 2007 and is focused ...
... Networks , the nation,s leading provider of physician office-based ... consumer purchase behavior, not just purchase intent, for OTC ... revenue and justify investments designed to capture market share, ... health messages to purchase volume. To address this need ...
... aged 70-79, the apparent association between light-to-moderate alcohol consumption ... not hold up after adjustments were made for characteristics ... education, and income. The authors of the ... American Geriatrics Society , say this suggests that life-style ...
... SAN DIEGO, Oct. 14 Cardium Therapeutics (NYSE Amex: ... Matrix Phase 2b clinical trial of Excellarate(TM) for the ... ulcers based on the Company,s Gene Activated Matrix (GAM) ... the Excellarate product candidate (GAM501, which is a combination ...
... Continuing its efforts to educate, inform, and empower ... patient-focused organization, is hosting its 25-minute live call-in show, ... Monday, October 19, 2009 at 6:00 PM on Channel ... frank discussion regarding Retail Health Clinics with Erin Buckley, ...
Cached Medicine News:Health News:Fight to Preserve Flexible Spending Accounts Moves to the House of Representatives 2Health News:Fight to Preserve Flexible Spending Accounts Moves to the House of Representatives 3Health News:NEA Promotes Ravi Viswanathan to General Partner and Names Frank Torti to Principal Post 2Health News:NEA Promotes Ravi Viswanathan to General Partner and Names Frank Torti to Principal Post 3Health News:Healthy Advice Networks Now Able to Track Consumer Purchase Behavior 2Health News:Healthy Advice Networks Now Able to Track Consumer Purchase Behavior 3Health News:'Beneficial' effects of alcohol? 2Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 2Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 3Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 4Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 5Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 6Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 7Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 8Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 9Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 10Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 11Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 12Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 13Health News:Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program 14Health News:Retail Health Clinics - The Real Story 2
(Date:3/2/2015)... , March 2, 2015  CANTEL MEDICAL CORP. ... Andrew A. Krakauer , CEO, will be presenting at ... Investor Forum. The formal presentation is scheduled for 2:00 ... Grand Hyatt Hotel, New York . ... Senior VP-Corporate Development, will be available for separate one-on-one ...
(Date:3/2/2015)... For the past 15 years, there has been an average of ... (U.S. Census Bureau 2012). Of course, not every accident is severe ... quite a few where the car occupants can get stuck in ... release button or occupant injury. One may be ... lifetime but may still be "lucky" enough to come upon an ...
(Date:3/2/2015)... , March 2, 2015   Mast ... biopharmaceutical company, today announced preliminary findings from a ... a model of chronic, stable heart failure produced ... study was to examine the effects of repeat ... systolic and diastolic function. Consistent ...
Breaking Medicine Technology:New SuperVizor, an Automobile Escape Tool, Ensures the Safety of Drivers and Passengers on the Road 2Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 2Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 3Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 4Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 5Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 6
... in Poor Risk Frontline Elderly AML and in Combination with Cytarabine ... Call Scheduled for Tuesday, December 9 at 11:00 am ET to ... , SAN FRANCISCO , Dec. 7 ... the presentation of new data from two ongoing clinical trials demonstrating ...
... carisbamate, an,investigational compound recently filed with the FDA for ... 16 years of age and,older, was presented today during ... American Epilepsy Society. , ... efficacy, safety and tolerability of carisbamate as an,adjunctive treatment ...
Cached Medicine Technology:Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 2Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 3Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 4Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 5Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 6Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 2Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 3Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 4Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 5
Slitlamp-mounted contact tonometer for precision tonometry (corneal thickness independent)...
The REVEALRT and REVEALXVI PET/CT scanners combine our fastest PET scanner, the REVEALXL, with multi-slice spiral CT scanners from Siemens Medical Systems....
Introducing the Guidant HEARTSTRING Proximal Seal System. A surgically intuitive system that meets the challenge of clampless hemostasis with a design that is elegant in its simplicity and profound i...
... Nidek MC-7000 is designed to treat ... glaucoma, age- related- macular- degeneration, and retinal ... compact design will allow physicians and health ... office, clinic, and surgical theater. Internally Water-cooled: ...
Medicine Products: